Indiatimes

VisionGATE is proud to announce All India Rank 1 for GATE Exams with their student, Jayadeep More

MUMBAI, India, March 17, 2023 /PRNewswire/ -- GATE Results were announced on 16th March, 2023 and Mr Jayadeep More a student of VisionGATE from Mumbai has achieved a remarkable feat by securing the ...
FiercePharma

VISIONGATE CLOSES $2 MILLION FINANCING AND ANNOUNCES COLLABORATION TO EVALUATE ITS 3D CELL IMAGING PLATFORM FOR EARLY LUNG CANCE

VISIONGATE CLOSES $2 MILLION FINANCING AND ANNOUNCES COLLABORATION TO EVALUATE ITS 3D CELL IMAGING PLATFORM FOR EARLY LUNG CANCER DETECTION -Study at Sheba Medical Center Is Assessing Ability of ...
EurekAlert!

Data shows VisionGate's 3D imaging platform accurately detects lung cancer in sputum

Sydney, Australia and Phoenix, AZ, USA – October 28, 2013 – VisionGate, Inc., a company developing a revolutionary non-invasive test for the early detection of lung cancer, today reported clinical ...
Fierce Healthcare

VisionGate Uses $2.6 Million NIH Grant to Achieve Full Automation of Cell-CT 3D Imaging System for Early Diagnosis of Cancer

PHOENIX, Jan. 6, 2012 /PRNewswire via COMTEX/ -- VisionGate, Inc., a company developing a revolutionary non-invasive test for the early detection of lung cancer and other applications, today reported ...
FierceBiotech

—Full Automation is Major Advance Enabling Wide Use of Cell-CT 3D Imaging System in Routine Clinical Practice—

PHOENIX, Jan. 6, 2012 /PRNewswire/ -- VisionGate, Inc., a company developing a revolutionary non-invasive test for the early detection of lung cancer and other applications, today reported that it has ...
EDN

VisionGate selects MathStar to help deliver Cell-CT cellular characterization platform

The folks at VisionGate, a privately held corporation in Washington State, have developed a novel 3D cellular characterization platform, the Cell-CT, based on the company's broadly patented technology ...
GEN

VisionGate Begins Collaborations to Evaluate 3-D Cell Analysis Test for Lung Cancer Screening

Trials will test LuCED test either alone or in combination with x-ray CT in primary screening and to monitor lung cancer patients post surgery. VisionGate announced a collaboration with the Sheba ...
FierceBiotech

VisionGate sets sights on FDA approval for noninvasive lung cancer Dx

As lung cancer diagnostics pick up steam in the industry, Phoenix, AZ-based VisionGate is looking to distinguish itself from the pack with its noninvasive test for the disease. And the company is ...
The Business Journals

VisionGate automates 3D cell microscope

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. VisionGate Inc., which has a <a href="http://www ...
Business Insider

VisionGate is Leveraging the Cell-CT™ Platform to Expand Cancer Diagnostics Services, Biopharmaceutical Services and Cancer Prevention Medicines

SEATTLE, WA, April 05, 2018 (GLOBE NEWSWIRE) -- VisionGate, a clinical stage oncology pharmaceutical and diagnostics company, is pleased to announce today the advancement of its breakthrough ...
AZ Central

Anatomy of a med-tech startup: VisionGate

Description: A non-invasive test for lung cancer in which patient sputum samples are processed on a system that computes 3-D images of the cells. About: Alan Nelson, a physicist by training, had ...
Security

VisionGate Selects MathStar to Help Deliver Innovative Cell-CT(TM) Cellular Characterization Platform

Dr. Alan Nelson , VisionGate's chairman and CEO, said, "MathStar's FPOA architecture provides the performance and flexibility to implement the computationally demanding filtering and backprojection ...